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ABSTRACT
Introduction: Millions of smokers use the Internet for
smoking cessation assistance each year; however,
most smokers engage minimally with even the best
designed websites. The ubiquity of mobile devices and
their effectiveness in promoting adherence in other
areas of health behaviour change make them a
promising tool to address adherence in Internet
smoking cessation interventions. Text messaging is
used by most adults, and messages can proactively
encourage use of a web-based intervention. Text
messaging can also be integrated with an Internet
intervention to facilitate the use of core Internet
intervention components.
Methods and analysis: We identified four aspects of
a text message intervention that may enhance its
effectiveness in promoting adherence to a web-based
smoking cessation programme: personalisation,
integration, dynamic tailoring and message intensity.
Phase I will use a two-level full factorial design to test
the impact of these four experimental features on
adherence to a web-based intervention. The primary
outcome is a composite metric of adherence that
incorporates general utilisation metrics (eg, logins,
page views) and specific feature utilisation shown to
predict abstinence. Participants will be N=860 adult
smokers who register on an established Internet
cessation programme and enrol in its text message
programme. Phase II will be a two-arm randomised
trial to compare the efficacy of the web-based
cessation programme alone and in conjunction with
the optimised text messaging intervention on 30-day
point prevalence abstinence at 9 months. Phase II
participants will be N=600 adult smokers who register
to use an established Internet cessation programme
and enrol in text messaging. Secondary analyses will
explore whether adherence mediates the effect of
treatment condition on outcome.
Ethics and dissemination: This protocol was
approved by Chesapeake IRB. We will disseminate
study results through peer-reviewed manuscripts and
conference presentations related to the methods and
design, outcomes and exploratory analyses.
Trial registration number: NCT02585206.
INTRODUCTION
Background and rationale
Tobacco use is the leading cause of prevent-
able death in the USA, causing 480 000 pre-
mature deaths among adults and nearly $289
billion in total economic burden each year.1
Reducing population smoking prevalence
can save more lives and money than almost
any other preventive intervention. Internet
interventions are a promising delivery
Strengths and limitations of this study
▪ This study will improve adherence to proven
web-based cessation interventions, which is crit-
ical to leveraging the potential public health
impact of this ‘broad reach’ treatment modality.
The potential scientific and public health impact
of this study is likely to extend beyond web-
based cessation programmes to other health risk
behaviours.
▪ The proposed study is innovative in its use of an
optimised text messaging intervention as an
adherence strategy.
▪ Study findings will add to the growing knowl-
edge base about the overall effectiveness of
Internet cessation programmes and mechanisms
through which their population impact on
smoking prevalence can be improved.
▪ A limitation of this study is that it examines a
limited number of factors related to adherence.
Although multiple factors influence use of web-
based cessation programmes, we cannot
examine all factors relevant to adherence, but
will measure theory-driven constructs to inform
our interpretation of results.
▪ This study also does not specifically target indi-
viduals with certain psychiatric or medical
comorbidities known to impact smoking cessa-
tion rates. If findings are supported, future
studies will further refine text message protocols
to focus on subgroups at greater risk of smoking
relapse.
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channel for cessation treatment that have potential for
enormous public health impact.2 The reach of web-
based cessation programmes is unparalleled. Millions of
smokers search online for quit smoking information
each year,3 and hundreds of thousands register on web-
based cessation programmes offered by quitlines in 51
US states and territories and Canada,4 by hundreds of
employers and health plans throughout the US,5 or on
publicly available, high-volume web-based cessation pro-
grammes around the globe.6–8 Quit rates in Internet
programmes range from 18% to 20% at 1 year9–11 and
greater intensity of use yields higher quit rates.12–17
However, most smokers engage minimally with even
the best designed cessation websites, visiting only one to
two times and not using many of the interactive tools or
community support that promote abstinence.15 18–21 As
a result, the full potential of Internet cessation pro-
grammes to reduce smoking prevalence and save lives is
yet to be realised. Poor adherence has been extensively
documented across dozens of Internet studies,18 22–35
systematic reviews,36–40 reviews of systematic reviews41
and meta-analyses42 across a range of health behaviours,
and is so pervasive it has been described as a ‘fundamen-
tal methodological challenge in the evaluation of
eHealth applications’ (ref. 30, p. 2).30 This is not a phe-
nomenon unique to one or two websites or to smoking
cessation. Adherence is traditionally defined as ‘the
extent to which a person’s behaviour corresponds with
agreed upon recommendations from health care provi-
ders’.43 Since many Internet interventions have no speci-
fied prescriptions for use,38 adherence may best be
defined as ‘the extent to which individuals experience
the content of the intervention’,24 or simply, ‘use of the
eHealth intervention over time’.44 Adherence is typically
measured by utilisation metrics such as number of visits
to a website, page views, interactive features used and
time on site.42 44 45
Periodic prompts and automated reminders can boost
intervention adherence.46 47 Several studies have exam-
ined the effectiveness of email prompts on website
engagement,23 25 35 48–50 finding that email contacts
generally yield more logins,36 but only among a small
proportion of study participants.49 50 Other elements
that improve adherence to web-based cessation pro-
grammes include multiple modes of delivery51 and indi-
vidually tailored communications.22 52 Together, these
studies support the use of (1) frequent automated
reminders, (2) supplemental modes of communication
and (3) a tailored approach to increase adherence to a
web-based cessation programme. These converging lines
of evidence inform the intervention design of this
protocol.
Given the reach of mobile phones, text messaging is
an ideal form of supplemental communication for
prompts and reminders to promote adherence.35 53 54
In October 2014, 90% of US adults owned a mobile
phone.55 The vast majority of mobile phone owners
(81%) use text messaging, including those most likely to
smoke: 85% of African Americans, 78% with household
income <$30 000/year and 77% with a high school
degree send and receive text messages.56 Mobile phone
owners over 18 years of age send and receive an average
of 42 texts/day.57 Text message interventions have been
shown to increase medication adherence58–60 and
appointment attendance,61–66 and to promote smoking
cessation in the short term67–69 and long term.70
However, few studies have included both web and text
programmes components,21 71 72 and those that have
included both modalities offered to them in parallel
with little to no integration between the two platforms,
potentially missing powerful synergies. To our knowl-
edge, no studies have examined text messaging to
promote adherence to web-based cessation treatment or
potential mechanisms of effectiveness.70
The mechanisms through which text messages influ-
ence behaviour are understudied, and no studies have
systematically varied characteristics of text message pro-
grammes.73 Based on communication and behaviour
change theories, the empirical literature, and our prior
work, we identified four aspects of a text message inter-
vention that may enhance its effectiveness in promoting
adherence to a web-based cessation programme: personal-
isation, integration, dynamic tailoring and message intensity.
Personalisation
According to the Elaboration Likelihood Model,74
people are more likely to actively process information if
they perceive it to be personally relevant. Personally rele-
vant messages may stimulate more thorough consider-
ation of a proposed behaviour change.75 Personalisation
uses person-specific elements, such as gender, age,
name, etc, to enhance the perceived relevance of a
message.76 Prior studies show that personalisation can
increase smokers’ attention to written information and
the perceived quality of that information.77 78 Across a
range of health behaviours, personalised text message
and web-based interventions have been found to be
more efficacious than generic interventions.42 79
Personalisation is also important to and desired by text
users.80 81
Strengths and limitations of this study
▪ Although text messaging is nearly ubiquitous in 2016 at the
start of the trial, we are aware of early reports that the number
of text messages sent has declined recently, potentially due to
the adoption of instant multimedia messaging applications
such as Snapchat and WhatsApp. With the increasing use of
smartphones and growing use of instant messaging applica-
tions, the use of text messaging may continue to decline.
However, the number of text messages sent each year remains
in the billions, ensuring that this technology will remain rele-
vant for the foreseeable future. In addition, the lessons learnt
from this trial about how best to use text messaging to facili-
tate intervention engagement will be relevant to smartphone
apps.
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Integration
A meta-analysis by Webb et al51 found that the effective-
ness of Internet interventions for a variety of health
behaviours was enhanced by text messages (d=0.81,
k=4). However, in the four studies reviewed, the Internet
interventions were used simply to gather data needed to
tailor the text message programme; the Internet and
text programmes operated in parallel with little to no
integration. Similarly, a more recent study by Borland
et al21 tested the combined effects of web and text for
smoking cessation, but there was little integration
between the two. To date, no studies have examined the
effectiveness of a truly integrated web and text interven-
tion in improving treatment adherence and cessation
outcomes.72 82–84 Addressing these questions has great
practical relevance given the number of existing web-
based cessation programmes that currently offer text
messaging as an adjunct service.4 The Webb et al51
meta-analysis provides an empirical basis for the current
study, in which a fully-integrated, multimodal interven-
tion using evidence-based components of a web-based
intervention is facilitated via interactive text messages.
The goal is to enable users to engage with the compo-
nents of a web-based intervention via interactive text
messages. The ability to interact with and use the tools
of a web-based programme via interactive text messages
may be more effective in promoting treatment adher-
ence than delivering static text messages that simply
refer to a web-based programme.
Dynamic tailoring
Whereas personalisation targets more superficial and
often unchanging elements of a message (ie, name,
gender, age), tailored communications target theory-
driven constructs related to a specific desired outcome.85
Decades of research on tailored interventions—includ-
ing tailored text message interventions79—have yielded
positive effects on health behaviour change and partici-
pation in health promotion programmes.79 86 87
Consistent with the Elaboration Likelihood Model,74 88
tailored messages are thought to be more effective due
to the greater degree of cognitive processing they elicit;
tailored messages are more likely to be read, understood,
recalled, rated highly and perceived as credible.88
However, tailored interventions most often rely on a
static assessment of variables used for tailoring. Indeed,
most automated text messaging programmes are static in
nature, tailored only to baseline variables. Few studies
have dynamically tailored communications to deliver
ipsative feedback (within-subject change).88 With the
advent of mobile devices and the ability to gather ‘real-
time’ data, there is exciting potential to tailor communi-
cations to incorporate changes in an individual’s
behaviour to provide a ‘smart’ intervention that adapts
as the needs of the individual change.89 Dynamic text
message interventions that change over time in
response to a user’s interaction with the programme
and progress in quitting are a promising target for next
generation, scalable systems for behaviour change.90
The current study will mimic a face-to-face treatment
approach in which participants are given feedback
about their treatment progress, reminded about inter-
vention features/content they have not yet used and
encouraged to remain engaged with treatment.38
Tailoring text messages based on a participant’s previous
pattern of engagement with treatment and recommend-
ing ‘next steps’ may be more efficacious than requiring
users to find their own way through a web-based
intervention.
Message intensity
Lastly, text message programmes typically involve an
automated programme of messages based around a self-
selected quit day.67 For example, in the txt2stop study,
Free et al91 delivered an intensive protocol of 35 mes-
sages/week for 5 weeks with an abrupt drop to three
messages/week for the remaining 26 weeks. A
meta-analysis by Head et al79 of text message interven-
tions across a range of health behaviours found that
intervention efficacy varied by message intensity, with
the largest effect size observed for programmes with
decreasing intensity (d=0.52, 95% CI 0.44 to 0.61).
Decreasing text message protocols tend to taper the
intervention from one phase to the next to gradually
decrease content delivery. To date, no study has expli-
citly examined the impact of various levels of message
intensity or identified the optimal intensity for a
smoking cessation text message intervention. Decreasing
message intensity—especially in conjunction with per-
sonalisation, interactivity and/or dynamic tailoring—
may be more salient and impactful than unchanging
intensity.
Findings from this study will yield important insights
into improving adherence for web-based cessation pro-
grammes around the globe. Many of these programmes
offer text messaging as an adjunct service alongside a
web-based programme, but none to date that integrate
Web and text programmes so that they seamlessly and
dynamically work together. Results from this study will
identify strategies for integrating these services to
promote adherence and improve quit rates, and will
identify specific features and functionality to include in
a text programme.
The potential scientific and public health impact of
this study is likely to extend beyond web-based cessation
programmes. Millions of adults use the Internet for
assistance with addictions and other health behaviours.92
Across healthcare, adherence is a problem that plagues
numerous therapies.43 Results from this study may
inform advances in intervention design to better engage
users and sustain their involvement across a range of
evidence-based programmes. Given the demonstrated
use of web-based interventions among hundreds of thou-
sands of minimally-engaged smokers who want to quit, it
is critical to advance scientific understanding about how
to better engage users so they receive the optimal dose
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of treatment necessary for abstinence. The need to
improve adherence is clear: even the best treatments will
have little impact if they are not used.
Objectives
The overarching goal of this study is to more effectively
engage the hundreds of thousands of minimally
engaged smokers already using the Internet to quit
smoking. As shown in figure 1, this two-phase study will:
(1) identify the factors in a text message intervention
that yield optimal adherence to a web-based smoking
cessation intervention (Phase I), and (2) examine the
comparative effectiveness of a web-based cessation inter-
vention alone (WEB) and in conjunction with the
optimal-adherence text messaging intervention (WEB
+TXT; phase II).
Specifically, in phase I, the study will examine the
impact of four experimental features of a text message
intervention on a composite metric of adherence to a
web-based cessation intervention. We hypothesise that
personalisation, integration, dynamic tailoring and
decreasing message intensity will have positive effects on
adherence. Phase II will address two aims. Aim 1 will
examine the comparative effectiveness of a web-based
cessation intervention alone (WEB) or in conjunction
with an optimised text messaging intervention (WEB
+TXT) with regard to 30-day point prevalence abstinence
at 9 months postrandomisation (primary outcome) and
adherence metrics (secondary outcomes). We hypothe-
sise that WEB+TXT will yield higher rates of abstinence
and adherence than WEB. Aim 2 will examine whether
the impact of treatment assignment on cessation is
Figure 1 Overall research design.
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mediated by adherence. We hypothesise treatment group
differences in 30-day point prevalence abstinence at
9 months will be mediated by greater levels of adherence
at 3 months to a web-based cessation programme.
Trial design
This two phase study will be conducted with registered
users on BecomeAnEX.org, an established and widely
used smoking cessation website run by Truth Initiative.
Phase I involves the initial development and optimisation
of the text message intervention. We will examine the
impact of four experimental text message intervention
features on smokers’ adherence to a web-based cessation
intervention during the first 3 months of programme
enrolment. We will utilise a full factorial design where
participants will be randomised to 1 of 2 levels of each of
the following features: (1) personalisation (yes/no), (2)
integration (yes/no), (3) dynamic tailoring (yes/no)
and (4) message intensity (standard vs decreasing). The
primary outcome in phase I will be a composite metric
of website adherence. Phase II involves a two-arm rando-
mised trial that compares WEB alone to WEB plus the
text message intervention from phase I that yields
optimal adherence (WEB+TXT). The randomised trial
will use a repeated-measures design, with assessments at
baseline, 3, 9 and 15 months postrandomisation.
Follow-ups at 3, 9 and 15 months correspond to 0, 6 and
12 months post-treatment. The primary outcome is
30-day point prevalence abstinence (ppa) at 9 months.
Other outcomes include motivation to quit smoking,
number of quit attempts and continuous abstinence.
Design considerations
Text messaging versus smartphone app
We chose a text message intervention over a smartphone
app for several reasons: (1) a majority of mobile phone
owners across most demographic groups use text messa-
ging (excepting those aged 65+ years), especially young
adults aged 18–29 years and minority groups such as
African Americans and Hispanics;93 (2) 80% of mobile
users send/receive text messages compared to only 43%
who download apps;93 (3) text messaging is a proven
cessation modality whereas smartphone apps are not;
(4) app installation may feel intrusive: 57% of app users
uninstall/decline to install apps due to privacy con-
cerns.94 Text programmes require minimal personal
data and may feel less intrusive; (5) smartphone pene-
tration (56%) lags behind high rates of mobile use.95
Use of full versus fractional factorial design
Fractional factorial designs for evaluating multicompo-
nent interventions have become popular96 97 and have
been used in several web-based cessation trials.98–100
Their popularity is partly based on the ability to rapidly
screen a large number of intervention components for
main effects, using a fraction of the treatment compo-
nent combinations required for a full factorial design. A
potential downside of fractional factorial designs is that
they require a formal refinement phase to resolve inter-
actions aliased with main effects and to evaluate the
optimal dose of factors with more than two levels. The
addition of a refinement phase makes the total sample
size and study duration for phase I hard to estimate in
advance, since the exact nature of follow-up experiments
to be conducted is highly dependent on the screening
phase. Given only N=4 factors and their binary nature—
and the fact that we incur no costs for participant
recruitment and have an ample pool to recruit from—
we will use a full factorial design that makes use of all
24=16 combinations of intervention components. Since
we have no aliasing issues to resolve and no need to
conduct additional experiments to determine optimal
factor doses, we can finalise our text intervention based
on phase I results where sample size and duration can
be fixed in advance.
Decision to power for interactions versus main effects
As shown by Chakraborty et al,97 2k factorial designs are
grossly underpowered for detecting simple effects
(ie, changes in individual factors while keeping all
remaining factors fixed). Rather, they gain power by
focusing on main effects (ie, averages of all 2k−1 simple
effects obtained by varying an individual factor at fixed
levels of the remaining factors). For example, a simple
effect of personalisation would correspond to compari-
sons of arms 1 vs 9 in figure 1, whereas its main effect
would correspond to a comparison of arms 1–8 (perso-
nalisation=no) with 9–16 (personalisation=yes). A focus
on main effects is acceptable during a screening experi-
ment to identify inactive components rather than in
evaluating the usefulness of a particular treatment com-
bination compared to the effects of each component
alone. Intervention components with null effects will be
dropped from further consideration, while optimum
levels for the remaining factors will be set based on their
signs in the regression model, with levels having positive
signs being associated with higher engagement. In prin-
ciple, one could observe a situation in which the joint
effect of two protective factors is lower in magnitude
than the sum of their main effects; such subadditivity is
not a concern given the negligible cost of offering add-
itional intervention components, as long as the joint
effect of the two factors exceeds each of their main
effects considered alone. Failure of the latter condition
would correspond to a strongly antagonistic interaction
that manifests itself in some pharmacological trials, but
which we consider unlikely to occur in a web interven-
tion. We have chosen a sample size that allows us to
identify and explain any such strongly antagonistic
two-way interactions.
METHODS AND ANALYSIS
This clinical trial protocol was prepared in accordance
with the Standard Protocol Items Recommendations for
Interventional Trials (SPIRIT) checklist.101 102
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Phase I Methods
Participants
In phase I, participants will be N=860 adult US smokers
who are new registered users on BecomeAnEX (ie, no
prior use of the site as determined by IP address and
registration data) and who fully enrol in the
BecomeAnEX text messaging programme. During regis-
tration, participants must indicate current smoking
(every day or some days), age 18 years or older, and US
zip code as determined by IP address.
Enrolment
New BecomeAnEX members who meet eligibility cri-
teria will be automatically randomised to 1 of 16 arms of
the factorial. Study enrolment will be conducted in
10 months. Based on our prior work, we conservatively
estimate that N=3/day (∼90/month) new members of
BecomeAnEX will enrol in text messaging.
Allocation and blinding
Randomisation will be stratified by whether participants
access the Internet on their cell phone (yes/no), since
access to BecomeAnEX via mobile site may influence
adherence. Randomisation will be automated using a
computer algorithm. The allocation sequence for the
full factorial will be generated by the study statistician at
study start-up and uploaded into the web-based clinical
trials management system that will automate its imple-
mentation. All investigators and research staff will
remain blinded to treatment assignment throughout the
conduct of the study.
Phase I Interventions
Participants are free to use the interventions described
below for as long as they desire. Proactive emails from
the WEB programme can be stopped at any time,
and users can unsubscribe from the text message pro-
gramme at any time. There are no restrictions on use
of other cessation interventions during the study
period.
Web-based cessation programme
BecomeAnEX is an evidence-based cessation pro-
gramme that was launched in 2008 by Truth Initiative
(formerly the American Legacy Foundation).19 103
Based on the Clinical Practice Guideline for Treating
Tobacco Dependence104 and consistent with Social
Cognitive Theory,105 the site educates smokers and pro-
vides the tools necessary to enhance self-efficacy for quit-
ting. BecomeAnEX guides and supports smokers
through the following interactive components: (1) a
Quit Date tool that assists users in selecting a quit date;
(2) Cigarette Tracker exercise to identify smoking trig-
gers; (3) Beat Your Smoking Triggers exercise to identify
strategies to dissociate cigarettes from triggers; (4) Build
Your Support System exercise to identify helpful suppor-
ters; (5) Choose a Quit Smoking Aid exercise, in which
users indicate their plans for pharmacotherapy use; and
(6) Community, a large online network of current and
former smokers who communicate via personal mes-
sages sent directly between members, public ‘wall posts’
(comments on a user’s profile page) and blog posts/
replies. The site can be browsed anonymously but to
save information, visitors must register. Registration
includes smoking status, gender and age, email, user-
name/password and request for email messages. Sign-up
for text messaging occurs during registration, and
involves providing a mobile number and affirming the
request. A mobile web version includes the full function-
ality of the site.
Text messaging
Truth initiative has developed a fully-automated text
messaging programme that is available via
BecomeAnEX. Users can set a quit date and receive
scheduled messages tailored to their quit date; quit
dates may be changed or cleared as frequently as a user
desires. Messages tailored to quit date encourage use of
evidence-based cessation methods (eg, nicotine replace-
ment therapy, peer support), praise success, inform
users about addiction and reinforce benefits of quitting.
Users who do not set a quit date receive scheduled mes-
sages tailored to their enrolment date. These messages
prompt users to set a quit date, use evidence-based
resources, and reinforce benefits of quitting and harms
of continuing to smoke. Keywords (eg, ‘COPE,’ ‘SLIP,’
‘MOOD’) allow users to request on-demand support
related to cravings, relapse and negative affect. ‘STOP’
terminates the programme at any time. The existing text
message intervention will be modified to serve as the
base case (arm 1) in phase I. The intervention will be
neither personalised, nor integrated with BecomeAnEX,
nor dynamically tailored, and will use a standard
message intensity delivery schedule (see study arm 1 in
figure 1). For study arms 2–16, we will modify approxi-
mately half the messages to ensure adequate differenti-
ation between factor levels, while preserving a coherent
user experience. We will user-test messages prior to the
launch of phase I to obtain feedback about their persua-
siveness, relevance, likelihood of stimulating a response
and appeal. We will also obtain user feedback about
message intensity (eg, desired message frequency, dur-
ation of text intervention) and integration between Web
and text via interactive messages.
Factor 1—Personalisation
Personalisation has been implemented in varying ways in
text message studies, ranging from participant name
only106 to name plus numerous pieces of personal infor-
mation.107 We will personalise text messages using the
participant’s BecomeAnEX username and gender.
Factor 2—Integration
Interactive messages will facilitate engagement via text
with the 6 interactive intervention components of the
BecomeAnEX website listed above. Set Quit Date is
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already a feature of the text message programme; the
system tailors messages around a quit date. Unlike most
other text message programmes that require a quit date
—and consistent with our aim to improve adherence to
a web-based intervention among all users—we will
deliver 3 months of text messages regardless of whether
a user sets a quit date. When a user sets a quit date via
the website, it will trigger text messages tailored to that
quit date. All participants, regardless of randomisation
assignment, will be able to set their quit date via text
message and have this information reflected on the
website. To enable participants to interact with the
Cigarette Tracker, Beat Your Smoking Triggers, Build
Your Support System and Choose a Quit Smoking Aid
exercises via text message, an initial text message will
query the user for a response. Subsequent messages will
elicit additional user input (eg, other triggers), highlight
relevant content on BecomeAnEX (eg, how to cope with
boredom) and reinforce use of the site. To facilitate
interaction in the Community via text message, we will
develop a new Community feature called ‘QuickTips’
that will enable BecomeAnEX members to submit text
message-sized tips to help support other members. We
will enable BecomeAnEX members to submit QuickTips
via website, mobile site, or text message. Submissions will
undergo review/approval by the BecomeAnEX
Administrator before being distributed via text message.
The Administrator will augment the QuickTips library as
needed, excerpting community content to craft ‘user-
generated’ tips. Text users can also request QuickTips
for on-demand ‘peer support’.
Factor 3—Dynamic tailoring
The general principle guiding implementation of this
feature is that messages will be individually tailored to
remind/reinforce users about BecomeAnEX informa-
tion/tools they have already used, or to prompt users to
take actions they have not yet taken. Although
BecomeAnEX and the text message system are separate
systems, they will communicate via an application pro-
gramming interface, which will allow BecomeAnEX to
alert the text message system of site utilisation. Real-time
site utilisation data will tailor text messages to encourage
the participant to use components of the website they
have not yet used or reinforce ongoing use.
Factor 4—Message intensity
The text message intervention will be 12 weeks in dur-
ation. For the standard intensity protocol, participants
will receive a consistent number of messages each day.
The decreasing intensity protocol will deliver approxi-
mately the same total number and content of messages
as the standard intensity protocol, but with additional
tapering steps designed to mirror the declines in crav-
ings and withdrawal typically experienced by a smoker
after quitting.108 The decreasing protocol will gradually
reduce the number of daily messages, rather than
sharply decrease as in the standard intensity protocol.
We will examine the relationship between ‘dose’ of text
messages received and our composite adherence metric.
Phase I Measures
Phase I will rely on data from 4 sources: (1)
BecomeAnEX registration data, (2) automated tracking
data gathered through Adobe Analytics109 software, (3)
automated tracking data stored in unified event logs and
(4) text message utilisation data. Use of the following
components of BecomeAnEX will be extracted from
unified event logs: Set Quit Date, Cigarette Tracker, Beat
Your Smoking Triggers, Choose your Quit Smoking Aid,
Build Your Support System and Community (eg, # of
wall posts made/received, blog posts/replies, messages
sent/received, QuickTips submitted). From our text
message system, we will extract replies to interactive text
messages including engagement with the six interactive
features of BecomeAnEX, unsubscribe rates, modal day
of unsubscribe, number of days enrolled, messages
received and keyword requests. All text interactions are
date/time stamped.
Primary outcome
The primary outcome of phase I will be a composite
metric of adherence for each participant created using a
weighted sum of general measures of engagement (eg,
visits, page views, time on site) and specific feature util-
isation shown to predict abstinence during 3 months
postenrolment. The weights for these utilisation metrics
will be given by the regression coefficients of a logistic
regression model that we have already developed to
measure the effects of website engagement on three-
month abstinence rates in the control arm of a prior
ongoing web-based cessation study.110 The resulting
adherence metric has the advantage that it is continu-
ously distributed, even if some of the original utilisation
metrics are binary or count data. Therefore, it can be
analysed as the primary outcome for phase I using stand-
ard linear regression techniques, possibly after a normal-
ising transformation. Treatment duration of 3 months
will provide sufficient time to examine the impact of the
text message intervention on adherence, since most
non-usage attrition happens within the first 3 months.19
Phase I Data analysis plan and sample size calculations
Analysis plan
We expect the primary outcome to be continuously dis-
tributed, although it may require a symmetrising trans-
formation to reduce skewness. Given our prior
experience with these data, we expect to find a few out-
liers that represent heavy website users. Rather than
discard such valid data points, we will reduce their
impact by winsorisation (similar to trimming).111 Once
we are satisfied about the adequacy of the normal
approximation, we will analyse the data from our factor-
ial designs using the approach detailed in the paper by
Chakraborty et al.97
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Sample size calculations
To be conservative, we used a sample size for phase I
that allows us to detect small main effects of any of the
four factors of interest (d=0.25) or moderate two-way
interactions (d=0.50) with power 80% at a two-sided sig-
nificance level of α=0.05/10 (multiplicity adjustment
based on four main effects and six two-way interactions
in the model). Effect sizes for interactions were chosen
to be such that they could nullify the presumed benefi-
cial main effects of the factors involved. The sample size
required is N=430 per factor level, or N=860 overall.
These calculations were not adjusted for attrition since
we will have adherence data on all participants.
Phase II Methods
Subjects
We will recruit a separate sample of N=600 adult
smokers who register on BecomeAnEX and sign up for
text messaging during registration. To be invited, partici-
pants must be adult current smokers (every day/some
days) who register on BecomeAnEX and enrol in the
text message programme. Invited participants will com-
plete a separate screening process to confirm eligibility.
To maximise generalisability, we have no inclusion cri-
teria related to motivation for cessation.
Recruitment and enrolment
Phase II participants will not be enrolled automatically
as in phase I, but must respond to a study invitation and
complete online eligibility screening, provide informed
consent, undergo a baseline assessment and fully enrol
in the text messaging programme. Study enrolment
occurs online via our web-based clinical trials manage-
ment system. Randomisation will only occur after a
potential study participant has completed the online
enrolment process (completed baseline survey) and
replied ‘OK’ to the welcome text message to confirm
text message enrolment. Randomisation will be stratified
by gender, age (≤30, 30+ years), and whether partici-
pants access the Internet on their cell phone (yes/no)
since age and access to BecomeAnEX via mobile site
may influence adherence and gender may influence ces-
sation outcomes. A computer algorithm will automate
random allocation. Recruitment will be conducted over
14 months.
Interventions
WEB: Participants will have full access to BecomeAnEX.
They will not receive any intervention via text message.
Informed consent will explain the possibility of being
randomised to a non-text treatment arm. WEB+TXT:
Participants will have full access to BecomeAnEX and
the optimal-adherence text intervention developed in
phase I. Participants are free to use the interventions for
as long as they desire. Proactive emails from the WEB
programme can be stopped at any time, and users can
unsubscribe from the text message programme at any
time. There are no restrictions on use of other cessation
interventions during the study period. Use of other quit
methods will be assessed at all follow-up intervals.
Retention
We expect at least 70% follow-up at 9 months. To maxi-
mise follow-up we will: (1) provide clear information
about the study at the outset, including expectations for
follow-up; (2) reimburse participants $50 per follow-up;
and (3) emphasise the importance of survey completion
regardless of smoking status. If follow-up rates are lower
than expected early in the trial, we will consider shorten-
ing the 9-month follow-up to gather only abstinence
outcomes.
Phase II Measures
Assessments will occur at baseline, 3, 9 and 15 months
postrandomisation. The baseline survey will be con-
ducted online and hosted on a secure server.
Mixed-mode follow-up (email, phone, text) will be
employed. Telephone surveys will be conducted by
research staff blind to treatment. Text messages have
demonstrated moderately high reliability (k=.66) com-
pared with web-based surveys in assessing smoking out-
comes112 and will be used as a final means of gathering
abstinence data from non-responders. Most measures
listed below are standard instruments used in cessation
studies, and are reliable when administered via the
Internet.113 114
Baseline variables
To characterise the sample and examine moderators, we
will gather information on: demographics (age, sex,
marital status, race, ethnicity, employment and educa-
tion); current smoking behaviour and smoking history
(smoking frequency and rate; quitting history, including
quit methods; current and past use of other tobacco pro-
ducts); nicotine dependence assessed by the Heaviness
of Smoking Index;115 motivation to quit smoking mea-
sured with the Readiness Ladder;116 mobile phone type/
use (average number of text messages sent/received
each day, cell phone use to access the Internet, send or
receive email,93 data plan on phone117 and where, how
and how often they access the Internet); and smoking
cessation self-efficacy measured with the short form of
the Smoking Situations Confidence Questionnaire.118
Outcome measures
The primary outcome is self-reported 30-day ppa at
9 months postrandomisation but we will gather abstin-
ence data at all follow-ups. Other smoking-related out-
comes will include change in motivation to quit, quit
attempts, 7-day ppa and continuous abstinence measured
at each follow-up. Intervention satisfaction in both condi-
tions will be measured with items about overall satisfac-
tion, perceived helpfulness, whether the intervention
met their expectations (1=not at all, 5=very much) and
whether they would recommend the intervention to a
friend (1=definitely not, 5=definitely would). Satisfaction
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with frequency/duration of text messages, and percep-
tions about Internet and text message integration, will
also be measured.71 To assess perceived message rele-
vance, participants will be asked whether text messages
‘were written personally for you’22 and ‘were directed at
you personally’ (1=not at all, 7=very much).76
Mediating variables
We will examine the same website utilisation metrics as
in phase I from Adobe Analytics109 and unified event
logs. Adobe Analytics will provide metrics for contact
time (total time spent logged into the website), number
of website sessions (number of return visits to the
website), use of the static content on the site (number
of page views) and number of videos watched. Unified
event logs will provide data on use of the six interactive
components of BecomeAnEX and the platform on
which they were used (ie, website or mobile site). We
will extract replies to interactive text messages including
engagement with the six interactive features of
BecomeAnEX and number of keyword requests from
the text message system. Unsubscribe rates, modal day of
unsubscribe, number of days enrolled and messages
received, will be extracted. All text message interactions
are date and time stamped.
Phase II data analysis plan and sample size calculations
The distributional properties of continuously scaled vari-
ables will be examined to determine the need for nor-
malising transformations. Next, we will determine
whether the groups show large standardised mean differ-
ences at pretreatment on demographic characteristics,
psychosocial variables or smoking variables. Although
the large sample size should preclude finite sample ran-
domisation imbalances, should such between-group dif-
ferences be found, we will correct for them via
regression adjustment.
Outcome analyses
Our primary outcome for aim 1 is self-reported 30-day
ppa. Differences in abstinence rates between the two
treatment conditions will be evaluated at our primary
endpoint of 9 months postrandomisation, as well as the
secondary endpoints of 3 and 15 months post-
randomisation. To account for within-subject correlation
due to the repeated-measures aspect of our study, we will
employ the Generalised estimating equation, which
extends generalised linear model methodology to corre-
lated data in PROC GENMOD of SAS/STAT (SAS Inc,
Cary, North Carolina, USA). Analyses will be conducted
first using an intention-to-treat (ITT) principle, analys-
ing data from all participants randomised to treatment
and counting as smokers those lost to follow-up
(missing=smoking).
Moderator analyses
We will examine potential moderators of the
intervention-smoking cessation relationship (eg, gender,
baseline stage of motivational readiness, nicotine
dependence). Effect modification will be conducted by
analysing interactions between treatment and selected
variables.
Mediator analyses
Primary aim 2 hypothesises that adherence mediates the
intervention-cessation relationship. We will establish
mediation using the MacKinnon approach.119 As
explained in Cerin and MacKinnon120 and implemented
by Papandonatos et al,121 behavioural researchers ought
to determine whether: (A) the intervention successfully
acted on the putative mediator (ie, ‘Action Theory
test’); (B) changes in the mediator were indeed predict-
ive of changes in the target behaviour suggested by the
conceptual framework underpinning the intervention
over and above any direct treatment effects
(ie, ‘Conceptual Theory test’); and (C) these conditions
held simultaneously for each mediator of interest,
indicating that the corresponding mediational
pathway accounted for at least part of the relationship
between the intervention and the target behaviour
(ie, ‘Mediation test’).
Missing data
We expect less than 25% missing data at any time. If a
participant refuses follow-up, we will censor the data at
the point of loss of contact. Under an ITT approach,
participants who had been considered non-smokers up
to the point of loss will be considered smokers at future
data points. One concern is that this approach is sensi-
tive to differential attrition across study arms and tends
to overestimate precision of estimates of treatment
effects.122 Therefore, we will supplement ITT analyses
with a multiple imputation procedure that assumes the
odds of missingness vary for smokers and non-smokers
lost to follow-up. This model falls under the
missing-not-at-random (MNAR) characterisation of miss-
ingness mechanisms by Little and Rubin,123 and
requires knowledge of the OR relating missingness to
smoking. Since this OR is in practice unknown, we will
conduct a sensitivity analysis to assess its impact on the
estimate and significance of the intervention
effect.124 125
Sample size
Efficacy estimates for WEB are based primarily on the
BecomeAnEX trial110 and the BecomeAnEX Outcome
Evaluation,19 augmented by results from our iQUITT
Study126 and the American Cancer Society (ACS)
trial.12 127 In our ongoing BecomeAnEX trial,110 30-day
ppa using ITT at 9 months in the Internet-alone arm is
8.8%. In the BecomeAnEX Outcome Evaluation,19
30-day ppa using ITT at 6 months was 9.9%. Quit rates
for the web programmes in The iQUITT Study ranged
from 12.2%-14.4% at 6 months (30-day ppa ITT). In the
ACS trial12 7-day ppa (ITT) at 13 months was 8–12%
across all five interactive websites and 10% for the static
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site. We conservatively estimate that the 30-day ppa rate
at 9 months for WEB will be 9% under ITT. Efficacy esti-
mates for WEB+TXT are based on several converging
lines of evidence: (1) a meta-analysis by Webb et al51
found that the parallel use of text messaging in Internet
interventions had large effects on behaviour change
(d=0.81, k=4); (2) abstinence rates in the BecomeAnEX
Outcome Evaluation19 at 6 months were roughly
doubled among those who used the community
(OR=2.22, 95% CI 1.34 to 3.69, p=0.002) and separation
exercises (OR=1.91, 95% CI 1.00 to 3.65, p=0.05) two or
more times compared to those with no utilisation;
increased adherence to these features facilitated by text
messages is expected to increase abstinence similarly;
(3) Brendryen et al72 tested a multicomponent cessation
intervention that included parallel Internet and text
messaging, which yielded 12-month repeated ppa of
20% under ITT. We conservatively estimate that the
30-day ppa rate at 9 months for WEB+TXT will be 16.5%
under ITT, corresponding to an intervention OR=2.0,
which can be detected with 80% at two-sided α=0.05
using N=300 per study arm (N=600 total).
Study monitoring
At the start of the study, a Data Safety Monitoring
Committee will be established, comprised of the
Principal Investigator, Data Analyst, Biostatistician,
Technical Lead and Project Manager. This committee
will discuss protocol development and will review scien-
tific, safety and ethical issues related to the study design,
and approve plans for data integrity. The committee will
meet every 2 weeks to review the following information
in detail: (1) participant accrual rate, (2) participant
drop-out and the reasons for drop-out, (3) targeted
enrolment status, and (4) major and minor problems
related to treatment arm assigned.
The overall risk is judged to be very low for phase I
and phase II. Study participants who attempt to quit
smoking will likely experience some nicotine withdrawal
symptoms that may include anxiety, restlessness, anger,
irritability, sadness, problems concentrating, appetite
change and weight gain, insomnia and decreased heart
rate. There is no reason to believe that participation in
this study would worsen nicotine withdrawal symptoms
or that symptoms would differ based on randomisation
Figure 2 Phase I participant timeline.
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assignment in either phase I or phase II. Exposure to
evidence-based information and support for smoking
cessation in both the Internet and text message inter-
ventions is expected to attenuate withdrawal symptoms
associated with smoking cessation that may occur during
phase I or phase II. Given the nature of the trial, we do
not anticipate the need for interim analyses or stopping
guidelines. Serious adverse events are unlikely, but will
be reported immediately on discovery by study staff to
the Principal Investigator, who will notify the IRB and
NIH Project Officer within 24 h.
Participant timeline—phase I and phase II
The main outcome of interest for phase I is a composite
metric of adherence for each phase I participant created
using a weighted sum of general engagement metrics
(eg, website visits, page views, time on site) and specific
feature utilisation shown to predict abstinence during
3 months postenrolment. There is neither baseline nor
follow-up assessment for participants to complete as
adherence metrics are collected automatically.
Participants will receive the text message intervention
for 12 weeks and participants can discontinue at any
Figure 3 Phase II participant timeline.
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time by texting back ‘STOP’. The timeline for phase I is
depicted in figure 2.
The main outcome of interest for phase II is 30-day
point prevalence abstinence (ppa) at 9 months.
Secondary outcomes include 30-day ppa at 3 and
15 months, and adherence metrics. Participants will be
assessed at baseline to gather demographics; current
smoking behaviour and smoking history, nicotine
dependence assessed by the Heaviness of Smoking
Index; motivation to quit smoking measured with the
Readiness Ladder; mobile phone type and use; and
smoking cessation self-efficacy measured with the short
form of the Smoking Situations Confidence
Questionnaire. The intervention period will past for
3 months postrandomisation. Follow-up surveys will take
place for all participants at 3, 9 and 15 months postran-
domisation, during which they will be assessed on
smoking-related outcomes, including change in motiv-
ation to quit, quit attempts, 30-day ppa, 7-day ppa and
continuous abstinence; intervention satisfaction; and
perceived text message relevance. The baseline survey
will be conducted online. Mixed-mode follow-up (email,
phone, text) will be employed for all follow-up assess-
ments. The timeline for phase II is depicted in figure 3.
ETHICS AND DISSEMINATION
Research ethics approval
Institutional Review Board approval for the study was
provided by Chesapeake Institutional Review Board.
Protocol amendments
Any protocol modifications will be submitted for
approval to Chesapeake IRB and reflected (as needed)
in trial registry information available on ClinicalTrials.
gov.
Consent
New registrants on BecomeAnEX.org will be automatic-
ally enrolled in phase I following BecomeAnEX registra-
tion if they meet the eligibility criteria and complete
BecomeAnEX text message enrolment by replying ‘OK’
to the welcome message. To register on BecomeAnEX,
individuals must agree to the site’s Terms of Use and
Privacy Policy. The Privacy Policy makes explicit that (1)
Truth Initiative automatically collects information about
its users and their use of the site, (2) information is
used for research and quality improvement purposes
only, and (3) personal information is kept confidential.
Eligible individuals will be automatically randomised to
1 of 16 arms of the factorial design. Their use of the
BecomeAnEX website and text messages will be tracked
for 3 months. No additional screening information will
be requested or obtained and no separate informed
consent will be solicited as the registration process
makes it clear that the Truth Initiative may monitor all
registered users’ use of the website and that they are
explicitly agreeing to receive text messages.
In phase II, new registered users on BecomeAnEX are
presented the informed consent page and provided
detailed information about the study (see online supple-
mentary appendix A). Randomisation will only occur
after an eligible study participant has completed the
online enrolment process (confirmed eligibility, indi-
cated informed consent, confirmed contact information
and completed baseline survey) and replied ‘OK’ to the
welcome text message to confirm text message
enrolment.
Confidentiality
Confidentiality will be protected at all times and poten-
tial risks minimised systematically. During BecomeAnEX
registration, participants create a username and pass-
word that they use to log into the website. Each use of
BecomeAnEX involves a session ID unique to the user,
and the date and time of access. BecomeAnEX uses
industry standard security protocols. Users are automat-
ically logged out of BecomeAnEX after 30 min of
inactivity. The BecomeAnEX Privacy Policy will be in
effect for all participants enrolled in the project.
Transactional data from the site are loaded on a daily
basis into a local data warehouse that is provided with
both physical and electronic protection. Confidentiality
of data will be maintained by numerically coding all
data, by keeping identifying information separate from
research data and by keeping all data electronically pro-
tected. Identifying information will not be reported.
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